Vicarious Surgical (RBOT) Amortization of Deferred Charges (2021 - 2022)

Vicarious Surgical's (RBOT) quarterly Amortization of Deferred Charges came in at $50000.0 in Q4 2022, up 433.33% year-on-year from $9375.0 in Q4 2021, and up 525.0% on a QoQ basis from $8000.0 in Q3 2022.

Vicarious Surgical (RBOT) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends

Vicarious Surgical (RBOT) has 2 years of Amortization of Deferred Charges data on file, last reported at $50000.0 in Q4 2022.

  • On a quarterly basis, Amortization of Deferred Charges rose 433.33% year-over-year to $50000.0 in Q4 2022; TTM through Dec 2022 was $75000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $75000.0, up 257.14% from the prior year.
  • Amortization of Deferred Charges for Q4 2022 stood at $50000.0, up from $8000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for RBOT reached as high as $50000.0 in Q4 2022 and fell as low as -$15000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Vicarious Surgical 654,984.55 -9.14 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 50,000.00
Dec 31, 2022 50,000.00
Sep 30, 2022 8,000.00
Sep 30, 2022 8,000.00
Jun 30, 2022 9,000.00
Jun 30, 2022 9,000.00
Mar 31, 2022 8,000.00
Mar 31, 2022 8,000.00
Dec 31, 2021 -15,000.00
Dec 31, 2021 -15,000.00
Sep 30, 2021 27,000.00
Sep 30, 2021 27,000.00